TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment

Figure 4

Diagnostic value of TREM2 expression in SKCM. (a) ROC curve for TREM2 in normal tissue and SKCM. (b–e) Subgroup analysis for T1/T2, T3/T4, N0/N1-N3, and M0/M1.

(a)

(b)

(c)

(d)

(e)